Newsroom | 3341 results

Sorted by: Latest

Baby/Maternity
-

Beyond the Track: Sunday Swagger and Pennzoil Launch Performance-Inspired Lifestyle Collection Featuring Team Penske

YORBA LINDA, Calif.--(BUSINESS WIRE)--Sunday Swagger, the performance golf and lifestyle apparel company that never sacrifices comfort for personality, today announced a new collaboration with Pennzoil, a leading motor oil brand, that will feature Team Penske. Inspired by Pennzoil’s long-standing legacy in motorsports, its partnership with Team Penske, and its pursuit of performance and longevity on and off the track, the new Pennzoil x Sunday Swagger collection features 21 new products for men...
-

 AngelEye Health Demonstrates Alignment With U.S. News Neonatology Criteria in New Whitepaper

NASHVILLE, Tenn.--(BUSINESS WIRE)--AngelEye Health, a leader in neonatal and pediatric solutions, announced that six of the top 10 NICUs and 10 of the top 20 NICUs ranked in the 2025 U.S. News & World Report currently use the company’s technology, including Texas Children’s Hospital, Lucile Packard Children’s Hospital Stanford, and Nationwide Children’s Hospital. AngelEye’s solutions provide NICUs with the workflows, data, and proof needed to improve care delivery and reduce operational bur...
-

Alen BreatheSmart Air Purifiers Earn Mom’s Choice Awards® and Named a 2026 Scary Mommy Readers’ Choice Winner

AUSTIN, Texas--(BUSINESS WIRE)--Alen BreatheSmart Air Purifiers Earn Mom’s Choice Awards® and Named a 2026 Scary Mommy Readers’ Choice Winner...
-

Nexpring Health investit dans May Health pour faire progresser une technologie novatrice dans le traitement de l’infertilité liée au SOPK

BEVERLY, Massachusetts--(BUSINESS WIRE)--Nexpring Health, leader mondial des solutions de procréation médicalement assistée (PMA), a annoncé aujourd’hui un investissement stratégique dans May Health, une société de dispositifs médicaux pionnière dans une nouvelle approche thérapeutique pour les femmes souffrant d’infertilité liée au syndrome des ovaires polykystiques (SOPK). Nexpring Health s’est associé à May Health pour un tour de table de 10 millions d’euros (11,7 millions de dollars) aux cô...
-

Nexpring Health invierte en May Health para desarrollar una nueva tecnología para tratar la infertilidad relacionada con el síndrome de ovario poliquístico (SOP)

BEVERLY, Massachusetts--(BUSINESS WIRE)--Nexpring Health, líder internacional en soluciones de tecnología de reproducción asistida (TRA), ha anunciado hoy una inversión estratégica en May Health, una empresa de dispositivos médicos pionera en un novedoso enfoque terapéutico para mujeres con infertilidad relacionada con el síndrome de ovario poliquístico (SOP). Nexpring Health se ha sumado a la ronda de financiación de 10 millones de euros (11,7 millones de dólares) de May Health junto con inver...
-

Nexpring Health investeert in May Health om een nieuwe technologie voor de behandeling van PCOS-gerelateerde onvruchtbaarheid te ontwikkelen

BEVERLY, Mass.--(BUSINESS WIRE)--Nexpring Health, een wereldwijde leider op het gebied van oplossingen voor geassisteerde voortplantingstechnologie (ART), heeft vandaag een strategische investering aangekondigd in May Health. Dit bedrijf maakt medische hulpmiddelen en pioniert met een nieuwe behandelmethode voor vrouwen met onvruchtbaarheid door polycysteus ovariumsyndroom (PCOS). Nexpring Health heeft zich aangesloten bij de financieringsronde van € 10 miljoen ($ 11,7 miljoen) van May Health,...
-

Nexpring Health Invests in May Health to Advance a Novel Technology to Treat PCOS-Related Infertility

BEVERLY, Mass.--(BUSINESS WIRE)--Nexpring Health, a global leader in assisted reproductive technology (ART) solutions, today announced a strategic investment in May Health, a medical device company pioneering a novel treatment approach for women with polycystic ovary syndrome (PCOS)-related infertility. Nexpring Health joined May Health’s €10 million ($11.7M) financing round alongside investors including Sofinnova Partners, Trill Impact, and Bpifrance. This investment reflects Nexpring Health's...
-

Nexpring Health investiert in May Health, um neue Technologie zur Behandlung von PCOS-bedingter Unfruchtbarkeit voranzutreiben

BEVERLY, Massachusetts--(BUSINESS WIRE)--Nexpring Health, ein weltweit führender Anbieter von Lösungen im Bereich der assistierten Reproduktionstechnologie (ART), gab heute eine strategische Investition in May Health bekannt, ein Medizintechnikunternehmen, das Pionierarbeit in der Fruchtbarkeitsmedizin leistet, um einen neuen Behandlungsansatz für Frauen mit Polyzystischem Ovarsyndrom (PCOS) zu entwickeln. Nexpring Health beteiligt sich an der 10-Millionen-Euro-Finanzierungsrunde von May Health...
-

Nexpring Health investe in May Health per sviluppare una nuova tecnologia per il trattamento dell'infertilità associata alla PCOS (sindrome dell'ovaio policistico)

BEVERLY, Mass.--(BUSINESS WIRE)--Nexpring Health, un leader globale in soluzioni di tecnologia della riproduzione assistita (ART), oggi ha annunciato un investimento strategico in May Health, azienda produttrice di dispositivi medici pioniera di un nuovo approccio terapeutico per le donne con infertilità associata alla sindrome dell'ovaio policistico (PCOS). Nexpring Health ha partecipato al round di finanziamento di May Health da 10 milioni di euro (11,7 milioni di dollari) assieme a investito...
-

Inc. Names MilkMate Founder Patrice Hayden Meagher to Its 2026 Female Founders 500 List

NEW YORK--(BUSINESS WIRE)--MilkMate Products, Inc., the company that pioneered Breast Pumping as a Service (BPaaS) with the first zero-setup, zero-cleanup workplace lactation solution, is proud to announce that Patrice Hayden Meagher has been named to Inc.’s 2026 Female Founders 500, an annual list honoring the most dynamic women business leaders in the United States. The honor recognizes founders whose bold ideas, resilience, and execution are shaping the future of their industries. MilkMate r...